Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation
Open Access
- 26 September 2022
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-17
Abstract
This paper was designed to predict the mechanisms of the active components of Huaji Jianpi Decoction (HJJPD) against nonalcoholic fatty liver disease (NAFLD) based on network pharmacology-combined animal experiments. The candidate compounds of HJJPD and its relative targets were obtained from TCMSP and PharmMapper web server, and the intersection genes for NAFLD were discerned using OMIM, GeneCards, and DisGeNET. Then, the target protein-protein interaction (PPI) and component-target-pathway networks were constructed. Moreover, gene function annotation (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed to study the potential signaling pathways associated with HJJPD’s effect on NAFLD. Molecular docking simulation was preformed to validate the binding affinity between potential core components and key targets. Eventually, the candidate targets, the possible pathway, and the mechanism of HJJPD were predicted by the network pharmacology-based strategy, followed by experimental validation in the NAFLD mice model treated with HJJPD. A total of 55 candidate compounds and 36 corresponding genes were identified from HJJPD that are associated with activity against NAFLD, and then the network of them was constructed. Inflammatory response and lipid metabolism-related signaling pathways were identified as the critical signaling pathways mediating the therapeutic effect of the active bioactive ingredients on NAFLD. Compared with the model group, the liver wet weight, liver/body ratio, the levels of total cholesterol (TC), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and high-density lipoprotein (HDL) in serum in the HJJPD low-dose (17.52 g/kg·d), medium-dose (35.04 g/kg·d), and high-dose (70.07 g/kg·d) groups significantly decreased ( ). Light microscope observation shows that HJJPD could control the degree of lipid denaturation of the mouse liver tissue to a great extent. RT-qPCR results show that the mRNA expression levels of peroxisome proliferative activated receptor gamma (PPARG), tumor necrosis factor-α (TNF-α), antiserine/threonine protein kinase 1 (AKT1), and prostaglandin-endoperoxide synthase (PTGS2) in the liver tissues of the three HJJPD groups (17.52 g/kg·d, 35.04 g/kg·d, and 70.07 g/kg·d) were significantly lower than those in the model group ( ). HJJPD can exert its effect by inhibiting hepatic steatosis and related mRNA expression and decreasing the levels of other liver-related indexes. This study suggested that HJJPD exerted its effect on NAFLD by modulating multitargets with multicompounds through multipathways. It also demonstrated that the network pharmacology-based approach might provide insights for understanding the interrelationship between complex diseases and interventions of HJJPD.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (H208201218, ZD2020101, 2020, 2020-8)
- Science and Technology Research Key Project of Higher Education Department of Hebei Province (H208201218, ZD2020101, 2020, 2020-8)
- The Training Program for Outstanding Clinical Medical Talents, China (H208201218, ZD2020101, 2020, 2020-8)
- The Outstanding Youth Scientific Research and Innovation Team (Science and Technology) Project of Hebei University (H208201218, ZD2020101, 2020, 2020-8)
- Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation (H208201218, ZD2020101, 2020, 2020-8)
This publication has 46 references indexed in Scilit:
- Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive ComponentsMolecules, 2018
- Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver DiseaseCurrent Pharmaceutical Design, 2018
- Clinical epidemiology and disease burden of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2017
- Nonalcoholic Fatty Liver DiseasePrimary Care: Clinics in Office Practice, 2017
- The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trialTrials, 2017
- Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat studyBMC Complementary and Alternative Medicine, 2017
- MAPK1/3 regulate hepatic lipid metabolism via ATG7-dependent autophagyAutophagy, 2016
- Reversal of Multidrug Resistance by the Chinese Medicine Yiqi Jianpi Huaji Decoction and the Mechanism of Action in Human Gastric Cancer SGC7901/VCR CellsEvidence-Based Complementary and Alternative Medicine, 2015
- Self-assembled complex of probe peptide – E. Coli RNA I conjugate and nano graphene oxide for apoptosis diagnosisBiomaterials, 2012
- Steatosis in the Liver2011